Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0KA3L
|
|||
Drug Name |
Epoxysuccinate derivative 6
|
|||
Synonyms |
PMID25399719-Compound-23
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
|
|||
Structure |
Download2D MOL |
|||
Formula |
C16H15N3O5S
|
|||
Canonical SMILES |
C1=CC=C(C=C1)NC(=O)C(CC2=CSC=N2)NC(=O)C3C(O3)C(=O)O
|
|||
InChI |
1S/C16H15N3O5S/c20-14(18-9-4-2-1-3-5-9)11(6-10-7-25-8-17-10)19-15(21)12-13(24-12)16(22)23/h1-5,7-8,11-13H,6H2,(H,18,20)(H,19,21)(H,22,23)/t11-,12-,13-/m0/s1
|
|||
InChIKey |
SLAUAVANSQIASN-AVGNSLFASA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Calpain-2 (CAPN2) | Target Info | Inhibitor | [1] |
Target's Patent Info | Calpain-2 (CAPN2) | Target's Patent Info | [1] | |
KEGG Pathway | Protein processing in endoplasmic reticulum | |||
Apoptosis | ||||
Alzheimer's disease | ||||
Reactome | Degradation of the extracellular matrix | |||
WikiPathways | Focal Adhesion | |||
Integrated Pancreatic Cancer Pathway | ||||
Alzheimers Disease | ||||
Integrin-mediated Cell Adhesion |
References | Top | |||
---|---|---|---|---|
REF 1 | An updated patent review of calpain inhibitors (2012 - 2014).Expert Opin Ther Pat. 2015 Jan;25(1):17-31. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.